scispace - formally typeset
K

Karolina A. Aberg

Researcher at Virginia Commonwealth University

Publications -  87
Citations -  3375

Karolina A. Aberg is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: DNA methylation & Epigenetics. The author has an hindex of 28, co-authored 75 publications receiving 2795 citations. Previous affiliations of Karolina A. Aberg include Uppsala University & VCU Medical Center.

Papers
More filters
Journal ArticleDOI

Association of Childhood Trauma Exposure With Adult Psychiatric Disorders and Functional Outcomes

TL;DR: In this cohort study, cumulative childhood trauma was associated with higher rates of adult psychiatric disorders and poorer functional outcomes even after adjusting for a broad range of other childhood risk factors for these outcomes.
Journal ArticleDOI

Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults.

TL;DR: This methylome-wide association study of schizophrenia is one of the first MWASs of disease with a large sample size using a technology that provides good coverage of methylation sites across the genome and demonstratedone of the unique features ofmethylation studies that can capture signatures of environmental insults in peripheral tissues.
Journal ArticleDOI

Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia.

TL;DR: It is shown that human QKI mRNA levels can account for a high proportion of normal interindividual mRNA expression variation (and covariation) of six oligodendrocyte-related genes in 55 human brain autopsy samples from individuals without psychiatric diagnoses, and hypothesize that previously observed decreased activity of myelin- related genes in schizophrenia might be caused by disturbed QKI splicing.
Journal ArticleDOI

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

TL;DR: The potential of GWAS to discover genes and pathways that potentially mediate adverse effects of antipsychotic medication is shown, with the top finding indicated that a SNP in Meis homeobox 2 (MEIS2) mediated the effects of risperidone on hip circumference.